EDIT

EDITAS MEDICINE, INC.

EDIT · CIK 1650664 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$32M
20172024
Net Income−$237M
20172024
Operating CF−$210M
20172024
Free Cash Flow−$219M
20172024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Revenue$0.0B$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B—
Cost of Revenue————————
Gross Profit————————
R&D Expense$0.2B$0.2B$0.2B$0.1B$0.2B$0.1B$0.1B$0.1B
SG&A Expense————————
Operating Income$-0.3B$-0.2B$-0.2B$-0.2B$-0.1B$-0.1B$-0.0B$-0.1B
Net Income$-0.2B$-0.2B$-0.2B$-0.2B$-0.1B$-0.0B$-0.0B$-0.0B
EPS (Basic)$-2.88$-2.02$-3.21$-2.85$-1.00———
EPS (Diluted)$-2.88$-2.02$-3.21$-2.83$-1.00———

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Total Assets$0.3B$0.5B$0.5B$0.7B$0.6B$0.5B$0.4B$0.4B
Current Assets$0.3B$0.3B$0.4B$0.5B$0.4B$0.5B$0.4B$0.3B
Cash & Equivalents$0.1B$0.1B$0.1B$0.2B$0.1B$0.2B$0.1B$0.1B
Total Liabilities$0.2B$0.2B$0.2B$0.1B$0.2B$0.2B$0.2B$0.2B
Current Liabilities$0.1B$0.1B$0.1B$0.0B$0.1B$0.1B$0.0B$0.0B
Stockholders' Equity$0.1B$0.3B$0.4B$0.6B$0.4B$0.3B$0.2B$0.2B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Operating Cash Flow$-0.2B$-0.1B$-0.2B$-0.2B$-0.2B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$0.2B$-0.0B$0.1B$-0.1B$-0.1B$0.0B$-0.1B$-0.2B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Financing Cash Flow$0.1B$0.1B$0.0B$0.3B$0.2B$0.1B$0.1B$0.2B
← Companies